Clinical Trial Update: Comparative Study of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Morbidly Obese Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical Trial Update comparing sugammadex versus neostigmine for reversal of neuromuscular blockade in morbidly obese patients, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: University of Patras | Conditions: Morbid Obesity, Neuromuscular Blockade | Phase 2, Phase 3 | Status: UNKNOWN